Deerfield backs a Penn spinout aiming to shake up Parkinson’s treatments using stem cells, brain surgery

September 9, 2022

Click here to read the full subscription-only article.

Category: News

News Topics

Recent Posts

Innervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders

Series A financing round, led by Deerfield Management, to accelerate a new cell therapy

Related Articles

Innervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders

Series A financing round, led by Deerfield Management, to accelerate a new cell therapy modality